AKYNZEO
Active substance: NETUPITANT, PALONOSETRON
CAPSULE · NETUPITANT 300 mg/1, PALONOSETRON .5 mg/1
United StatesActive
Marketing holder: Helsinn Therapeutics (U.S.), Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- NETUPITANT · 300 mg/1
- PALONOSETRON · .5 mg/1
Products containing netupitant in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| EU 1 |
|
Registration
- Registration number
- 69639-101
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 69639-101 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69639-101 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69639-101 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 69639-101 · Verified 2026-10-09 · open in source